Sterling Investment Advisors, Ltd. Viatris Inc Transaction History

Sterling Investment Advisors, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$9.95 - $12.27 $149 - $184	15 Added 8.47%	192 $2,000
Q1 2022 May 03, 2022	BUY	$9.81 - $15.4 $19 - $30	2 Added 1.14%	177 $2,000
Q4 2021 Feb 02, 2022	SELL	$12.09 - $14.68 $749 - $910	-62 Reduced 26.16%	175 $2,000
Q3 2021 Nov 09, 2021	SELL	$13.25 - $15.13 $40,637 - $46,403	-3,067 Reduced 92.83%	237 $3,000
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $11,232 - $13,985	-866 Reduced 20.77%	3,304 $47,000
Q1 2021 May 04, 2021	SELL	$13.59 - $18.54 $23,605 - $32,203	-1,737 Reduced 29.41%	4,170 $58,000
Q4 2020 Jan 21, 2021	BUY	$14.3 - $18.74 $84,470 - $110,697	5,907 New	5,907 $111,000

1,091

966M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.